AMBALAL SARABHAI ENTERPRISES
Back to Balance Sheet
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹102 Cr | ₹103 Cr | ₹105 Cr | ₹129 Cr | ₹133 Cr |
What is the latest Total Current Liabilities ratio of AMBALAL SARABHAI ENTERPRISES ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹102 Cr |
Mar2023 | ₹103 Cr |
Mar2022 | ₹105 Cr |
Mar2021 | ₹129 Cr |
Mar2020 | ₹133 Cr |
How is Total Current Liabilities of AMBALAL SARABHAI ENTERPRISES Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹102 Cr | -0.54 | |
Mar2023 | ₹103 Cr | -2.46 | |
Mar2022 | ₹105 Cr | -17.95 | |
Mar2021 | ₹129 Cr | -3.69 | |
Mar2020 | ₹133 Cr | - |
Compare Total Current Liabilities of peers of AMBALAL SARABHAI ENTERPRISES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AMBALAL SARABHAI ENTERPRISES | ₹377.1 Cr | 12% | -13.4% | -18.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,132.0 Cr | 2.2% | -5.8% | 22.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,254.0 Cr | 4.1% | -7% | 52% | Stock Analytics | |
CIPLA | ₹116,123.0 Cr | 1.3% | -4.8% | 9.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,573.0 Cr | 2.2% | -10.9% | -0.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,966.9 Cr | 7% | -0.2% | 27.5% | Stock Analytics |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AMBALAL SARABHAI ENTERPRISES | 12% |
-13.4% |
-18.6% |
SENSEX | 2.8% |
-3.1% |
9% |
You may also like the below Video Courses